Daniel Krell
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
- Oncology 7
- Lung Cancer Research Studies 2
- Cancer Treatment and Pharmacology 2
- Pancreatic and Hepatic Oncology Research 1
-
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Paul Mulholland (5 shared papers)Chiara Bardella (3 shared papers)Justin Stebbing (5 shared papers)Jonathan Krell (4 shared papers)Adam E. Frampton (3 shared papers)Anna Jones (1 shared paper)Ian Tomlinson (2 shared papers)Malcolm Galloway (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)British Journal of Cancer (2 papers)PLoS ONE (2 papers)Journal of Neuroendocrinology (1 paper)Expert Review of Anticancer Therapy (1 paper)
- Partner nations
- United KingdomGermanyItaly
In The Last Decade
Daniel Krell
15 papers receiving 377 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 156
- Genetics 102
- Oncology 122
- Neurology 32
- Epidemiology 60
Countries citing papers authored by Daniel Krell
This map shows the geographic impact of Daniel Krell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Krell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Krell more than expected).
Fields of papers citing papers by Daniel Krell
This network shows the impact of papers produced by Daniel Krell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Krell. The network helps show where Daniel Krell may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Krell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 86 | |
| 2 | 2011 | 82 | |
| 3 | 2016 | 50 | |
| 4 | 2013 | 48 | |
| 5 | 2019 | 30 | |
| 6 | 2009 | 29 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 10 | |
| 9 | 2009 | 10 | |
| 10 | 2012 | 10 | |
| 11 | 2021 | 6 | |
| 12 | 2017 | 6 | |
| 13 | 2012 | 3 | |
| 14 | 2015 | 2 | |
| 15 | 2015 | 1 | |
| 16 | 2019 | 0 | |
| 17 | 2023 | 0 |
About Daniel Krell
Daniel Krell is a scholar working on Oncology, Cancer Research, Genetics, Epidemiology and Molecular Biology, having authored 17 papers that have together received 384 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (5 papers), Neuroendocrine Tumor Research Advances (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Lung Cancer Research Studies (2 papers), Cancer Treatment and Pharmacology (2 papers), Neuroblastoma Research and Treatments (2 papers), Epigenetics and DNA Methylation (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Cancer Research (156 citations), Genetics (102 citations), Oncology (122 citations), Neurology (32 citations) and Epidemiology (60 citations). Daniel Krell has collaborated with scholars based in United Kingdom, Germany and Italy. Frequent co-authors include Paul Mulholland, Chiara Bardella, Justin Stebbing, Jonathan Krell, Adam E. Frampton, Anna Jones, Ian Tomlinson, Malcolm Galloway, Leandro Castellano and Elisa Giovannetti. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, PLoS ONE, Journal of Neuroendocrinology and Expert Review of Anticancer Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.